laitimes

Hongri Pharmaceutical (300026.SZ): Net profit in the third quarter fell by 21.98% to 199 million yuan

On October 28, 2021, Hongri Pharmaceutical (300026.SZ) announced that in the first three quarters of 2021, the company achieved operating income of 5.486 billion yuan, an increase of 16.52% year-on-year; net profit attributable to shareholders of listed companies was 637 million yuan, an increase of 6.34% year-on-year. Among them, in the third quarter of 2021, the company achieved operating income of 2.000 billion yuan, an increase of 3.83% year-on-year; net profit attributable to shareholders of listed companies was 199 million yuan, down 21.98% year-on-year.

This article originated from Grand Gateway

Sun

Read on